Brisbane bio-tech firm lands $302 million U.S. contract for at-home COVID tests

Brisbane Firm Secures Historic $302M Contract

A Brisbane-based bio-tech company has made a groundbreaking move in the fight against COVID-19. But what does this massive contract mean for the future of at-home testing?

Read the full article →